一种非活性位点抑制剂,对寨卡病毒NS2B-NS3蛋白酶具有选择性
Kristalle G Cruz1, Maureen Hill Eron1, Sparsh Makhaik1
1Department of Chemistry, University of Massachusetts Amherst, Amherst, Massachusetts 01002, United States.
ACS infectious diseases
|January 24, 2024
概括
一种新型的抑制剂,MH1,通过结合一个全位选择性向寨卡病毒蛋白酶. 这一发现为开发新的黄病毒抑制剂提供了洞察力,通过专注于蛋白质动力学.
科学领域:
- 病毒学 病毒学
- 药物发现 药物发现 药物发现
- 分子生物学分子生物学
背景情况:
- 弗拉维病毒感染会导致发烧和头痛等症状,恢复时间长.
- 弗拉维病毒拥有七种非结构性蛋白质,为抗病毒疗法提供了潜在的点.
- 寨卡病毒NS2B-NS3蛋白酶对于病毒复制至关重要.
研究的目的:
- 为了识别和描述寨卡病毒NS2B-NS3蛋白酶的抑制剂.
- 研究一种新型抑制剂MH1的作用机制和选择性.
- 根据MH1的独特特性,探索开发泛病毒抑制剂的潜力.
主要方法:
- 生物化学测试以确定MH1对寨卡病毒蛋白酶 (ZVP) 的抑制度 (IC50).
- 基于细胞的测试来评估MH1在阻断病毒基质分裂和细胞病变效应方面的有效性.
- 构建混合蛋白酶以阐明MH1选择性的结构基础.
- 使用与活性位点抑制剂的协同抑制进行的结结合研究.
主要成果:
- MH1选择性地抑制ZVP,生物化学IC50为440nM,阻断细胞中的基质裂解.
- MH1对其他黄病毒蛋白酶和寨卡病毒细胞病变效应的抑制显著较弱.
- MH1结合到NS3蛋白酶域上的一个全位,破坏NS2B-NS3相互作用.
- 寨卡病毒NS2B的独特动态特性对MH1的抑制功能至关重要.
结论:
- MH1是一种独特的,选择性的Zika病毒蛋白酶抑制剂,在全位作用.
- MH1的选择性与NS2B辅因子的动态特性有关.
- 了解MH1的机制为开发新型非活性位点导向的黄病毒抑制剂提供了基础.
相关概念视频
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...


